sb 203580 has been researched along with Melanoma in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 10 (76.92) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersson, T; Axelsson, L; Jönsson, G; Linnskog, R; Prasad, CP | 1 |
| Choi, KC; Kook, SH; Lee, JC; Lee, SA; Son, YO | 1 |
| Benbow, U; Brinckerhoff, CE; Buttice, G; Tower, GB; Wyatt, CA | 1 |
| Eisen, TG; Smalley, KS | 1 |
| Cho, D; Hahm, E; Hur, D; Hwang, YI; Kang, JS; Kim, D; Kim, S; Kim, YI; Kim, YS; Lee, WJ; Pang, S; Park, H; Park, JH; Yang, Y | 1 |
| Creaven, BS; Egan, DA; Finn, GJ | 1 |
| Baguley, BC; Kelland, LR; Marshall, ES; Zhao, L | 1 |
| Akao, Y; Hirata, N; Iinuma, M; Matsuda, H; Naruto, S; Nozawa, Y; Ohguchi, K | 1 |
| Bae, S; Cho, BJ; Cho, D; Hahm, E; Hur, DY; Hwang, YI; Jung, DJ; Kang, JS; Kim, D; Kim, HW; Kim, JE; Lee, SK; Lee, WJ; Shin, DH | 1 |
| Ikejima, T; Onodera, S; Tashiro, S; Wu, LJ; Yang, J | 1 |
| Chiba, T; Hattori, T; Hayashi, H; Itoh, S; Lee, JC; Matsufuji, S; Mizutani, Y; Murakami, Y; Onozaki, K; Takii, T; Todo, M; Yang, D | 1 |
| Denkert, C; Hauptmann, S; Leclere, A; Siegert, A; Turzynski, A | 1 |
| Benbow, U; Brinckerhoff, CE; Coon, CC; Tower, GB; Vincenti, MP | 1 |
13 other study(ies) available for sb 203580 and Melanoma
| Article | Year |
|---|---|
Interleukin-6 drives melanoma cell motility through p38α-MAPK-dependent up-regulation of WNT5A expression.
Topics: Blotting, Western; Cell Line, Tumor; Cell Movement; Humans; Imidazoles; Interleukin-6; Melanoma; Oligopeptides; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins; Pyridines; Real-Time Polymerase Chain Reaction; Wnt Proteins; Wnt-5a Protein | 2014 |
Ascorbic acid increases the activity and synthesis of tyrosinase in B16F10 cells through activation of p38 mitogen-activated protein kinase.
Topics: alpha-MSH; Animals; Anti-Inflammatory Agents, Non-Steroidal; Ascorbic Acid; Deferoxamine; Disease Models, Animal; Enzyme Activation; Humans; Imidazoles; Intramolecular Oxidoreductases; MAP Kinase Signaling System; Melanins; Melanoma; Melanoma, Experimental; Mice; Microphthalmia-Associated Transcription Factor; Monophenol Monooxygenase; Oxidoreductases; Pyridines | 2011 |
High levels of MMP-1 expression in the absence of the 2G single nucleotide polymorphism is mediated by p38 and ERK1/2 mitogen-activated protein kinases in VMM5 melanoma cells.
Topics: Collagen Type I; DNA; DNA-Binding Proteins; Flavonoids; Gene Expression Regulation, Enzymologic; Imidazoles; Matrix Metalloproteinase 1; Melanoma; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; p38 Mitogen-Activated Protein Kinases; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Pyridines; Signal Transduction; Transcription Factors; Transfection; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator | 2002 |
Differentiation of human melanoma cells through p38 MAP kinase is associated with decreased retinoblastoma protein phosphorylation and cell cycle arrest.
Topics: alpha-MSH; Cell Differentiation; Colforsin; Dose-Response Relationship, Drug; Enzyme Inhibitors; G1 Phase; Humans; Imidazoles; Kinetics; MAP Kinase Signaling System; Melanins; Melanoma; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Neoplasm Proteins; Phosphorylation; Protein Processing, Post-Translational; Pyridines; Retinoblastoma Protein; Tumor Cells, Cultured | 2002 |
Vitamin C downregulates interleukin-18 production by increasing reactive oxygen intermediate and mitogen-activated protein kinase signalling in B16F10 murine melanoma cells.
Topics: Acetylcysteine; Animals; Antioxidants; Ascorbic Acid; Blotting, Western; Cell Line, Tumor; Densitometry; Down-Regulation; Enzyme Inhibitors; Flow Cytometry; Imidazoles; Immunoprecipitation; Interleukin-18; MAP Kinase Signaling System; Melanoma; Mice; p38 Mitogen-Activated Protein Kinases; Pyridines; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Skin Neoplasms; Time Factors | 2003 |
Activation of mitogen activated protein kinase pathways and melanogenesis by novel nitro-derivatives of 7-hydroxycomarin in human malignant melanoma cells.
Topics: Antineoplastic Agents; Cell Differentiation; Cell Line, Tumor; Colforsin; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Humans; Imidazoles; MAP Kinase Signaling System; Melanins; Melanoma; Mitogen-Activated Protein Kinases; Monophenol Monooxygenase; Nitro Compounds; Pyridines; Umbelliferones | 2005 |
Evidence for the involvement of p38 MAP kinase in the action of the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA).
Topics: Angiogenesis Inhibitors; Angiogenic Proteins; Animals; Cell Line, Tumor; Cell Proliferation; Cell Shape; Collagen; Dose-Response Relationship, Drug; Drug Combinations; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Laminin; MAP Kinase Signaling System; Melanoma; Mice; Mice, Nude; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Proteoglycans; Pyridines; RNA, Messenger; Xanthones; Xenograft Model Antitumor Assays | 2007 |
Mechanism of the melanogenesis stimulation activity of (-)-cubebin in murine B16 melanoma cells.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Enzymologic; Imidazoles; Lignans; Melanins; Melanoma; Mice; Monophenol Monooxygenase; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; RNA, Messenger | 2007 |
Vitamin C suppresses proliferation of the human melanoma cell SK-MEL-2 through the inhibition of cyclooxygenase-2 (COX-2) expression and the modulation of insulin-like growth factor II (IGF-II) production.
Topics: Animals; Ascorbic Acid; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2; Enzyme Activation; Enzyme Inhibitors; Humans; Imidazoles; Insulin-Like Growth Factor II; Melanoma; p38 Mitogen-Activated Protein Kinases; Pyridines; Receptor, IGF Type 1; RNA, Small Interfering; Vitamins | 2008 |
Nitric oxide activated by p38 and NF-kappaB facilitates apoptosis and cell cycle arrest under oxidative stress in evodiamine-treated human melanoma A375-S2 cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Enzyme Activation; Feedback, Physiological; Humans; Imidazoles; Melanoma; Membrane Potential, Mitochondrial; NF-kappa B; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Plant Extracts; Protein Kinase Inhibitors; Pyridines; Pyrrolidines; Quinazolines; Reactive Oxygen Species; Signal Transduction; Thiocarbamates; Time Factors; Tumor Suppressor Protein p53 | 2008 |
Antiproliferative effect of IL-1 is mediated by p38 mitogen-activated protein kinase in human melanoma cell A375.
Topics: Calcium-Calmodulin-Dependent Protein Kinases; Cell Division; Down-Regulation; Enzyme Activation; Enzyme Inhibitors; Growth Inhibitors; Humans; Imidazoles; Interleukin-1; Interleukin-6; Intracellular Fluid; Melanoma; Mitogen-Activated Protein Kinases; Ornithine Decarboxylase; Ornithine Decarboxylase Inhibitors; p38 Mitogen-Activated Protein Kinases; Polyamines; Proteins; Pyridines; RNA, Messenger; Tumor Cells, Cultured | 1999 |
An inhibitor of stress-activated MAP-kinases reduces invasion and MMP-2 expression of malignant melanoma cells.
Topics: Blotting, Northern; Cell Division; Enzyme Induction; Enzyme Inhibitors; Flavonoids; Gelatin; Gene Expression Regulation, Neoplastic; Imidazoles; MAP Kinase Kinase 1; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Melanoma; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; Neoplasm Proteins; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Pyridines; RNA, Messenger; RNA, Neoplasm; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Tumor Cells, Cultured | 2002 |
Erk 1/2 differentially regulates the expression from the 1G/2G single nucleotide polymorphism in the MMP-1 promoter in melanoma cells.
Topics: Enzyme Activation; Enzyme Inhibitors; Flavonoids; Gene Expression Regulation, Enzymologic; Humans; Imidazoles; Matrix Metalloproteinase 1; Matrix Metalloproteinase Inhibitors; Melanoma; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Phosphorylation; Polymorphism, Genetic; Promoter Regions, Genetic; Pyridines; Signal Transduction; Transcription, Genetic; Tumor Cells, Cultured | 2002 |